In an adult patient without contraindications, does a norepinephrine (Levophed) infusion or an epinephrine infusion raise heart rate more?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Epinephrine Increases Heart Rate More Than Norepinephrine

Epinephrine infusions cause significantly greater increases in heart rate compared to norepinephrine (Levophed) infusions. This is a consistent finding across multiple high-quality sources and reflects fundamental differences in their receptor pharmacology 1.

Pharmacologic Mechanism

The difference stems from their distinct adrenergic receptor profiles:

  • Epinephrine is a potent β1-adrenergic agonist that directly accelerates heart rate through positive chronotropic effects. It acts as "a much more powerful stimulant of cardiac function than norepinephrine" with substantially more β-adrenergic effects 1.

  • Norepinephrine has direct positive chronotropic effects, but these are typically counterbalanced by vagal reflex activity triggered by the blood pressure increase it causes. This baroreceptor-mediated reflex blunts or even reverses the direct heart rate effects 1.

Clinical Evidence

Direct Comparative Data

In healthy volunteers receiving continuous 6-hour infusions, epinephrine caused significant increases in heart rate while norepinephrine caused a significant decrease in heart rate 2. This demonstrates the opposing effects under controlled conditions.

In cardiogenic shock after acute MI, epinephrine caused significantly higher heart rates from H2 to H24 while norepinephrine kept heart rate unchanged (p < 0.0001) 3. This study was terminated early due to higher rates of refractory shock with epinephrine (37% vs 7%, p = 0.008).

Clinical Implications

The increased heart rate with epinephrine comes with important consequences:

  • Higher myocardial oxygen consumption and cardiac work 1, 4
  • Increased risk of tachycardia and arrhythmias compared to norepinephrine 1, 3
  • Elevated cardiac double product (heart rate × systolic BP), indicating greater myocardial oxygen demand 3

FDA-Labeled Effects

The FDA label for epinephrine explicitly states it causes "an increased heart rate (positive chronotropic action)" as one of its three primary mechanisms for raising blood pressure 5. This is a direct myocardial stimulation effect.

Important Caveats

Context matters for the net effect on heart rate:

  • In septic shock with baseline tachycardia, both agents may affect heart rate differently than in normocardic patients
  • The dose-dependent nature means higher doses of either agent will have more pronounced effects
  • Baseline cardiovascular state influences the magnitude of response 1

Bottom line: When choosing between these vasopressors, expect epinephrine to increase heart rate substantially more than norepinephrine, which may actually decrease heart rate through baroreceptor reflexes despite its direct chronotropic properties.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.